Date | Time | Source | Headline | Symbol | Company |
05/16/2024 | 7:00AM | GlobeNewswire Inc. | Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft® | NASDAQ:AXGN | Axogen Inc |
05/14/2024 | 7:00AM | GlobeNewswire Inc. | Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference | NASDAQ:AXGN | Axogen Inc |
05/02/2024 | 7:00AM | GlobeNewswire Inc. | Axogen, Inc Reports First Quarter 2024 Financial Results | NASDAQ:AXGN | Axogen Inc |
04/29/2024 | 4:50PM | GlobeNewswire Inc. | Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ | NASDAQ:AXGN | Axogen Inc |
04/16/2024 | 7:00AM | GlobeNewswire Inc. | Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 | NASDAQ:AXGN | Axogen Inc |
03/08/2024 | 5:33PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |
03/08/2024 | 5:31PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |
03/08/2024 | 4:38PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AXGN | Axogen Inc |
03/07/2024 | 6:12PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:AXGN | Axogen Inc |
03/07/2024 | 4:18PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:AXGN | Axogen Inc |
03/06/2024 | 8:59AM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:AXGN | Axogen Inc |
03/06/2024 | 8:53AM | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | NASDAQ:AXGN | Axogen Inc |
03/06/2024 | 8:45AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:AXGN | Axogen Inc |
03/05/2024 | 4:33PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |
03/05/2024 | 4:29PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AXGN | Axogen Inc |
03/05/2024 | 7:16AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AXGN | Axogen Inc |
03/05/2024 | 7:00AM | GlobeNewswire Inc. | Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results | NASDAQ:AXGN | Axogen Inc |
02/23/2024 | 4:03PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |
02/23/2024 | 4:02PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |
02/23/2024 | 4:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |
02/14/2024 | 3:22PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:AXGN | Axogen Inc |
02/13/2024 | 4:30PM | GlobeNewswire Inc. | Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 | NASDAQ:AXGN | Axogen Inc |
02/12/2024 | 1:21PM | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:AXGN | Axogen Inc |
02/06/2024 | 5:06PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:AXGN | Axogen Inc |
02/02/2024 | 4:15PM | GlobeNewswire Inc. | Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | NASDAQ:AXGN | Axogen Inc |
02/02/2024 | 9:29AM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:AXGN | Axogen Inc |
01/26/2024 | 11:49AM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:AXGN | Axogen Inc |
01/18/2024 | 5:00PM | GlobeNewswire Inc. | Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap | NASDAQ:AXGN | Axogen Inc |
01/11/2024 | 5:14PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |
01/11/2024 | 5:10PM | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |